Companies Home Search Profile

Periodic Benefit-Risk Evaluation Report PBRER -With Template

Focused View

Expert PV

7:55:01

58 View
  • 1. Overview of Course Content.mp4
    04:47
  • 2. Introduction and Basic Terminologies.mp4
    10:45
  • 3. Types of Aggregate Safety Reports.mp4
    03:28
  • 4. Concept of Periodicity.mp4
    09:38
  • 5. Regulatory timelines & guidelines.mp4
    07:10
  • 6. Importance & Significance of Aggregate Safety Reports in PV.mp4
    07:55
  • 7. Learning Evaluation - 1.html
  • 1. PBRER Key Objective.mp4
    09:45
  • 2. Principles of PBRER writing.mp4
    05:17
  • 3. PBRER Format & Template.mp4
    05:58
  • 4. PBRER Sections Overview.mp4
    22:14
  • 5. PBRER Appendices.mp4
    07:32
  • 6. PBRER vs PSUR.mp4
    04:10
  • 7. Learning evaluation - 2.html
  • 1. Section 1 Introduction.mp4
    06:32
  • 2. Section 2 Worldwide marketing authorization status.mp4
    06:17
  • 3. Section 3 Part I Actions taken in the reporting interval for safety reasons.mp4
    11:08
  • 4. Section 3 PART II Actions taken in the reporting interval for safety reasons.mp4
    10:15
  • 5. Section 4 Changes to reference safety information.mp4
    07:28
  • 6. Section 5 Estimated exposure and use patterns.mp4
    09:54
  • 7. Template- Section 5 Estimated exposure and use patterns.mp4
    11:35
  • 8. Section 6 Data in summary tabulations.mp4
    08:00
  • 9. Template, Appendix 2A, 2B for Section 6 Data in summary tabulations.mp4
    08:44
  • 10. Section 7 Summaries of significant findings from clinical trials.mp4
    11:17
  • 11. Template- Section 7 Summaries of significant findings from clinical trials.mp4
    03:54
  • 12. Section 8 Findings from non-interventional studies.mp4
    05:15
  • 13. Section 9 Information from other clinical trials and sources.mp4
    15:25
  • 14. Section 10 Non-clinical data.mp4
    05:19
  • 15. Section 11 Literature.mp4
    10:52
  • 16. Section 12 Other periodic reports.mp4
    04:31
  • 17. Section 13 Lack of efficacy in controlled clinical trials.mp4
    04:59
  • 18. Section 14 Late-breaking information.mp4
    06:36
  • 19. Signal Management Overview.mp4
    18:01
  • 20. Section 15 Overview of signals new, ongoing, or closed.mp4
    20:21
  • 21. Flow Chart - Signal & Risk Presentation.mp4
    08:26
  • 22. PBRER Template for draft guidance to Section 15 -Overview of Signals.mp4
    10:15
  • 23. Section 16 Signal and risk evaluation.mp4
    03:31
  • 24. 16.1 Summary of safety concerns.mp4
    05:09
  • 25. 16.2 Signal Evaluation.mp4
    07:31
  • 26. Section 16.3 Evaluation of risks and new information.mp4
    10:34
  • 27. Section 16.4 Risk Characterisation.mp4
    12:07
  • 28. Section 16.5 Effectiveness of risk management.mp4
    05:02
  • 29. PBRER Template for draft guidance to Section 16 Signal and Risk Evaluation.mp4
    23:25
  • 30. Section 17 Benefit Evaluation.mp4
    07:43
  • 31. PBRER Template for Section 17 Draft guidance.mp4
    05:39
  • 32. Section 18 Integrated benefit-risk analysis for authorised indications.mp4
    13:51
  • 33. PBRER Template guidance for Section 18.mp4
    05:59
  • 34. Section 19 Conclusions and actions.mp4
    03:48
  • 35. PBRER Template for Section 19 draft Guidance.mp4
    03:20
  • 36. References and Appendices.mp4
    06:24
  • 37. Learning Evaluation 3.html
  • 1. Introduction -Assessment reports in Aggregate Safety Reports.mp4
    04:38
  • 2. PSUSA Procedure in EMA & Types of AR.mp4
    04:13
  • 3. Post approval Regulatory requests.mp4
    03:51
  • 4. Template for PRAC Assessment Report.mp4
    09:14
  • 5. Learning Evaluation - 4.html
  • 1. Preparation for PBRER Production.mp4
    03:43
  • 2. Planning and Strategy.mp4
    09:31
  • 3. PBRER Authoring workflow.mp4
    11:05
  • 4. PBRER Review workflow.mp4
    04:33
  • 5. PBRER Submission.mp4
    06:27
  • 6. Learning Evaluation 5.html
  • Description


    Learn Key concepts of PBRER writing and guidance for draft exposure using a PBRER template

    What You'll Learn?


    • Aggregate Safety Reports in Pharmacovigilance: PBRER as a major aggregate report type, Using Template to learn PBRER drafting
    • Periodic Benefit Risk Evaluation Report (PBRER): Understanding concepts all PBRER sections with emphasis on Safety Sections
    • Understanding the process of authoring an Aggregate Safety report
    • EMA PSUSA Procedures: Handling PBRER Assessment reports [AR]
    • Project management for PBRER production: Workflows of authoring, review, strategy meetings, stakeholder interactions

    Who is this for?


  • Working Professionals in Pharmacovigilance with experience in Case processing, literature
  • Graduate or postgraduate degree in Medical sciences, Pharmaceutical sciences or Life sciences.
  • Beginners in PV training to explore concepts of aggregate safety reports[like PBRER] in Pharmacovigilance
  • What You Need to Know?


  • Understanding of Pharmacovigilance Fundamentals
  • Experience in PV ICSR Operations
  • Good quality of Internet connection
  • Basic level of English
  • More details


    Description

    This course is designed exclusively for professionals working in Pharmacovigilance ICSR Case management, aspiring to learn and explore other domains of PV, especially to shift their careers within PV from ICSR to writing aggregate safety reports.

    In Pharmacovigilance, Periodic Benefit-Risk Evaluation Report [PBRER] is a major aggregate safety report type which is accepted worldwide for periodic assessment of benefit risk profiles for the medicinal products that are in market.

    Each section of PBRER is explained with required fundamental content and utilised our PBRER Template to teach the drafting principles of PBRER.

    One of the experts in our community is a lead-trainer for the aggregate safety reports who has significant experience in drafting various kind of safety reports in pharmacovigilance, including project management. Our SME in this domain will take you through the PBRER concepts using template for your better understanding.

    You will learn following concepts in this course:


    • We will brush you with the basics of aggregate safety reports before starting PBRER concepts

    • We will provide theoretical background to PBRER [objectives, principles, report sections etc] to have a high-level overview before deep diving into each section of the report.

    • Now, you will enter into core section of the course, where you will learn each section and subsections of PBRER, including the key content and drafting concepts of PBRER.

    • After completion of our main part of course, we will explain what are PBRER - Assessment Reports and key concepts of PSUSA procedure in providing feedback to the PBRERs submitted by MAHs to the EMA.

    • At the end, we will provide bonus lectures by giving some project management tips that are essential for production of a PBRER which included general workflows of authoring, review, submissions, strategy meetings with key stakeholders etc.

    After completion of this course, you will gain new skill in fundamental concepts of aggregate safety reports including the key objectives and principles of drafting a PBRER. With that you can be confident to shift your career into this domain by facing interviews in Aggregate Safety Reports.

    Our Best Wishes to all learners to realise their professional dreams in their career!

    Who this course is for:

    • Working Professionals in Pharmacovigilance with experience in Case processing, literature
    • Graduate or postgraduate degree in Medical sciences, Pharmaceutical sciences or Life sciences.
    • Beginners in PV training to explore concepts of aggregate safety reports[like PBRER] in Pharmacovigilance

    User Reviews
    Rating
    0
    0
    0
    0
    0
    average 0
    Total votes0
    Focused display
    Category
    Hello!Warm Greetings from PV Experts Community!We are a group of professionals having expertise in Pharmacovigilance Sciences with over a decade of experience in various sub-domains of PV like ICSR operations, Literature Surveillance in Safety Sciences, Aggregate Safety Reports writing, Signal Management, Risk Management, Benefit-risk Assessments, product labelling, Insights on latest technology integrations using ML and AI technologies for increasing efficiencies in PV operations and deliverables.We strive to contribute for the PV community which helps in providing a better patient safety.Safety Sciences, especially post-marketing safety activities that we refer as Pharmacovigilance is a significant discipline for the wellbeing of humanity by making sure all patients receive medicines that are safe with no or little harm that can be mitigated easily. Students, Graduates, Post-graduates from medical, life sciences and pharmaceutical sciences have this Pharmacovigilance as relevant career option. Career in PV is corporate in nature with high pay for skills in demand like aggregate safety reports or signal / risk management.Trainings are structured specific to learners ranging from beginners to experienced working professionals to help in gaining relevant skills and knowledge in PV to flourish in their career by cracking job in PV easily and also by shifting internally to various domain within PV.Our group of experts in PV wishes every curious learner to have a successful career in Pharmacovigilance.Our Key Skills: PV Operations including ICSR- Case Management, Literature screening, Aggregate Safety Reports writing, Signal Management, Risk Management, Product Labelling, Handling Health Authority Enquiries, Referral Procedures, Agreements in PV, Third Party Audits & Health Authority Inspections, Pharmacovigilance System Master File [PSMF], Benefit-Risk Assessments, Setting Up Project in PV.
    Students take courses primarily to improve job-related skills.Some courses generate credit toward technical certification. Udemy has made a special effort to attract corporate trainers seeking to create coursework for employees of their company.
    • language english
    • Training sessions 57
    • duration 7:55:01
    • Release Date 2024/08/11